Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 128

1.

Rheological chaos of frictional grains.

Grob M, Zippelius A, Heussinger C.

Phys Rev E. 2016 Mar;93(3-1):030901. Epub 2016 Mar 14.

PMID:
27078280
2.

Expression of inhibitory receptors on intratumoral T cells modulates the activity of a T cell-bispecific antibody targeting folate receptor.

Schreiner J, Thommen DS, Herzig P, Bacac M, Klein C, Roller A, Belousov A, Levitsky V, Savic S, Moersig W, Uhlenbrock F, Heinzelmann-Schwarz VA, Umana P, Pisa P, Lardinois D, Müller P, Karanikas V, Zippelius A.

Oncoimmunology. 2015 Jun 24;5(2):e1062969. eCollection 2016 Feb.

PMID:
27057429
3.

Systemic inflammation in a melanoma patient treated with immune checkpoint inhibitors-an autopsy study.

Koelzer VH, Rothschild SI, Zihler D, Wicki A, Willi B, Willi N, Voegeli M, Cathomas G, Zippelius A, Mertz KD.

J Immunother Cancer. 2016 Mar 15;4:13. doi: 10.1186/s40425-016-0117-1. eCollection 2016.

4.

The immune system and cancer evasion strategies: therapeutic concepts.

Muenst S, Läubli H, Soysal SD, Zippelius A, Tzankov A, Hoeller S.

J Intern Med. 2016 Jan 8. doi: 10.1111/joim.12470. [Epub ahead of print] Review.

PMID:
26748421
5.

Trastuzumab emtansine (T-DM1) renders HER2+ breast cancer highly susceptible to CTLA-4/PD-1 blockade.

Müller P, Kreuzaler M, Khan T, Thommen DS, Martin K, Glatz K, Savic S, Harbeck N, Nitz U, Gluz O, von Bergwelt-Baildon M, Kreipe H, Reddy S, Christgen M, Zippelius A.

Sci Transl Med. 2015 Nov 25;7(315):315ra188. doi: 10.1126/scitranslmed.aac4925.

PMID:
26606967
6.

Metastatic spread in patients with non-small cell lung cancer is associated with a reduced density of tumor-infiltrating T cells.

Müller P, Rothschild SI, Arnold W, Hirschmann P, Horvath L, Bubendorf L, Savic S, Zippelius A.

Cancer Immunol Immunother. 2016 Jan;65(1):1-11. doi: 10.1007/s00262-015-1768-3. Epub 2015 Nov 5.

PMID:
26541588
7.

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.

Stahel RA, Riesterer O, Xyrafas A, Opitz I, Beyeler M, Ochsenbein A, Früh M, Cathomas R, Nackaerts K, Peters S, Mamot C, Zippelius A, Mordasini C, Caspar CB, Eckhardt K, Schmid RA, Aebersold DM, Gautschi O, Nagel W, Töpfer M, Krayenbuehl J, Ribi K, Ciernik LF, Weder W.

Lancet Oncol. 2015 Dec;16(16):1651-8. doi: 10.1016/S1470-2045(15)00208-9. Epub 2015 Nov 2.

PMID:
26538423
8.

Second-Line Therapy of Small-Cell Lung Cancer: Topotecan Compared to a Combination Treatment with Adriamycin, Cyclophosphamide And Vincristine (ACO) - a Single Center Experience.

Hagmann R, Hess V, Zippelius A, Rothschild SI.

J Cancer. 2015 Sep 15;6(11):1148-54. doi: 10.7150/jca.13080. eCollection 2015.

9.

Modulation of APC Function and Anti-Tumor Immunity by Anti-Cancer Drugs.

Martin K, Schreiner J, Zippelius A.

Front Immunol. 2015 Sep 29;6:501. doi: 10.3389/fimmu.2015.00501. eCollection 2015. Review.

10.

Fluctuation Analysis of Centrosomes Reveals a Cortical Function of Kinesin-1.

Winkler F, Gummalla M, Künneke L, Lv Z, Zippelius A, Aspelmeier T, Grosshans J.

Biophys J. 2015 Sep 1;109(5):856-68. doi: 10.1016/j.bpj.2015.07.044.

11.

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.

Pless M, Stupp R, Ris HB, Stahel RA, Weder W, Thierstein S, Gerard MA, Xyrafas A, Früh M, Cathomas R, Zippelius A, Roth A, Bijelovic M, Ochsenbein A, Meier UR, Mamot C, Rauch D, Gautschi O, Betticher DC, Mirimanoff RO, Peters S; SAKK Lung Cancer Project Group.

Lancet. 2015 Sep 12;386(9998):1049-56. doi: 10.1016/S0140-6736(15)60294-X. Epub 2015 Aug 11. Erratum in: Lancet. 2015 Sep 12;386(9998):1040.

PMID:
26275735
12.

Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors.

Thommen DS, Schreiner J, Müller P, Herzig P, Roller A, Belousov A, Umana P, Pisa P, Klein C, Bacac M, Fischer OS, Moersig W, Savic Prince S, Levitsky V, Karanikas V, Lardinois D, Zippelius A.

Cancer Immunol Res. 2015 Dec;3(12):1344-55. doi: 10.1158/2326-6066.CIR-15-0097. Epub 2015 Aug 7.

PMID:
26253731
13.

Integrated Akt/PKB signaling in immunomodulation and its potential role in cancer immunotherapy.

Xue G, Zippelius A, Wicki A, Mandalà M, Tang F, Massi D, Hemmings BA.

J Natl Cancer Inst. 2015 Jun 11;107(7). pii: djv171. doi: 10.1093/jnci/djv171. Print 2015 Jul. Review.

PMID:
26071042
14.

Mechanical properties of branched actin filaments.

Razbin M, Falcke M, Benetatos P, Zippelius A.

Phys Biol. 2015 Jun 4;12(4):046007. doi: 10.1088/1478-3975/12/4/046007.

PMID:
26040560
15.

Acute heart failure due to autoimmune myocarditis under pembrolizumab treatment for metastatic melanoma.

Läubli H, Balmelli C, Bossard M, Pfister O, Glatz K, Zippelius A.

J Immunother Cancer. 2015 Apr 21;3:11. doi: 10.1186/s40425-015-0057-1. eCollection 2015.

16.

Bevacizumab, Pemetrexed, and Cisplatin, or Bevacizumab and Erlotinib for Patients With Advanced Non-Small-Cell Lung Cancer Stratified by Epidermal Growth Factor Receptor Mutation: Phase II Trial SAKK19/09.

Gautschi O, Mach N, Rothschild SI, Li Q, Stahel RA, Zippelius A, Cathomas R, Früh M, Betticher DC, Peters S, Rauch D, Feilchenfeldt J, Bubendorf L, Savic S, Jaggi R, Leibundgut EO, Largiadèr C, Brutsche M, Pilop C, Stalder L, Pless M, Ochsenbein AF; Swiss Group for Clinical Cancer Research.

Clin Lung Cancer. 2015 Sep;16(5):358-65. doi: 10.1016/j.cllc.2015.02.007. Epub 2015 Mar 5.

PMID:
25843489
17.

Esterase activity of carbonic anhydrases serves as surrogate for selecting antibodies blocking hydratase activity.

Uda NR, Seibert V, Stenner-Liewen F, Müller P, Herzig P, Gondi G, Zeidler R, van Dijk M, Zippelius A, Renner C.

J Enzyme Inhib Med Chem. 2015 Dec;30(6):955-60. doi: 10.3109/14756366.2014.1001754. Epub 2015 Sep 4.

PMID:
25775095
18.

Therapeutic efficacy of the F8-IL2 immunocytokine in a metastatic mouse model of lung adenocarcinoma.

Wieckowski S, Hemmerle T, Prince SS, Schlienger BD, Hillinger S, Neri D, Zippelius A.

Lung Cancer. 2015 Apr;88(1):9-15. doi: 10.1016/j.lungcan.2015.01.019. Epub 2015 Jan 31.

PMID:
25682318
19.

Cancer immunology - development of novel anti-cancer therapies.

Rothschild SI, Thommen DS, Moersig W, Müller P, Zippelius A.

Swiss Med Wkly. 2015 Feb 4;145:w14066. doi: 10.4414/smw.2015.14066. eCollection 2015. Review.

20.

Phase diagram of selectively cross-linked block copolymers shows chemically microstructured gel.

von der Heydt A, Zippelius A.

J Chem Phys. 2015 Feb 7;142(5):054901. doi: 10.1063/1.4905831.

PMID:
25662662
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk